1. Home
  2. News
  3. Telix Pharmaceuticals Limited
  4. Telix, GMS & Monash Awarded $23 million Federal Funding
More Telix Pharmaceuticals Limited news
Telix Pharmaceuticals LimitedASX: TLX

Telix, GMS & Monash Awarded $23 million Federal Funding

Apr 4, 2022 at 12:21 AM EDT · Issued by Telix Pharmaceuticals Limited

Filed with ASX · Apr 4, 2022 at 12:21 AM EDT · 3 pages · English

On 6ix: 6ix.com/news/telix-gms-and-monash-awarded-dollar23-million-federal-funding

Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20↗

Telix Pharmaceuticals Limited on 6ix

Earlier from Telix Pharmaceuticals

  • Commercial Launch - Illuccix Now Available to Order in USApr 3, 2022
  • FDA Orphan Drug Designation for Bone Marrow ConditioningMar 29, 2022
  • Telix and Xiel Sign U.K. and Ireland Distribution AgreementMar 28, 2022
  • Development of Glioblastoma Therapy ProgramMar 22, 2022
  • Radiopharmaceutical Production Facility Buildout CommencesMar 21, 2022

Later from Telix Pharmaceuticals

  • Telix Enters Licence Agreement with Lilly for OlaratumabApr 10, 2022
  • ProstACT TARGET Phase II Study Ethics ApprovalApr 11, 2022
  • Appendix 4C and Activities Report for March 2022 quarterApr 21, 2022
  • Illuccix Reimbursement Milestone and Launch UpdatesMay 29, 2022
  • Leadership changes including Darren Smith appointment as CFOMay 31, 2022
All Telix Pharmaceuticals news releases↗

Follow Telix Pharmaceuticals into a list and get an email when it puts out news.

Follow Telix Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer